ArticleBreast cancer research : BCR2012

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term.

Rachel C Jankowitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.